Prolonged molecular remission in a newly diagnosed acute promyelocytic leukaemia with a severe cardiomyopathy using low-dose gemtuzumab ozogamicin and all-trans retinoic acid

被引:3
|
作者
Martini, Vincenza
Minotti, Clara
Breccia, Massimo
De Angelis, Gioia
Buffolino, Sonia
Mariella, Montano
Lo-Coco, Francesco
Avvisati, Giuseppe
Cimino, Giuseppe
机构
[1] Univ Roma La Sapienza, Dept Cellular Biotechnol & Haematol, I-00161 Rome, Italy
[2] Univ Roma Tor Vergata, Dept Haematol, Rome, Italy
[3] Univ Campus BioMed Rome, Dept Haematol, Rome, Italy
关键词
D O I
10.1007/s00277-006-0219-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:295 / 297
页数:3
相关论文
共 50 条
  • [1] Prolonged molecular remission in a newly diagnosed acute promyelocytic leukaemia with a severe cardiomyopathy using low-dose gemtuzumab ozogamicin and all-trans retinoic acid
    Vincenza Martini
    Clara Minotti
    Massimo Breccia
    Gioia De Angelis
    Sonia Buffolino
    Montano Mariella
    Francesco Lo-Coco
    Giuseppe Avvisati
    Giuseppe Cimino
    [J]. Annals of Hematology, 2007, 86 : 295 - 297
  • [2] All-trans retinoic acid and low-dose chemotherapy for acute promyelocytic leukaemia
    Sanz, MA
    Martínez, JA
    Barragán, E
    Martín, G
    Lo Coco, F
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (04) : 896 - 897
  • [3] Treatment of Relapsed Acute Promyelocytic Leukemia with Gemtuzumab Ozogamicin and All-Trans Retinoic Acid
    Tageja, N.
    Valent, J.
    Zonder, J.
    [J]. JOURNAL OF CHEMOTHERAPY, 2009, 21 (06) : 705 - 706
  • [4] All-trans retinoic acid in acute promyelocytic leukaemia
    Avvisati, G
    Tallman, MS
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2003, 16 (03) : 419 - 432
  • [5] Combination therapy with arsenic trioxide, all-trans retinoic acid, and gemtuzumab ozogamicin in recurrent acute promyelocytic leukemia
    Aribi, Ahmed
    Kantarjian, Hagop M.
    Estey, Elihu H.
    Koller, Charles A.
    Thomas, Deborah A.
    Kornblau, Steven M.
    Faderl, Stefan H.
    Laddie, Nakia M.
    Garcia-Manero, Guillermo
    Cortes, Jorge E.
    [J]. CANCER, 2007, 109 (07) : 1355 - 1359
  • [6] Pharmacokinetics and efficacy of low-dose all-trans retinoic acid in the treatment of acute promyelocytic leukemia
    Chen, GQ
    Shen, ZX
    Wu, F
    Han, JY
    Miao, JM
    Zhong, HJ
    Li, XS
    Zhao, JQ
    Zhu, J
    Fang, ZW
    Chen, SJ
    Chen, Z
    Wang, ZY
    [J]. LEUKEMIA, 1996, 10 (05) : 825 - 828
  • [7] Successful remission induction by low-dose all-trans retinoic acid alone in a patient with acute promyelocytic leukemia and renal impairment
    Matsumoto, Kengo
    Tamaki, Hiroya
    Yamagami, Tamotsu
    Sasaki, Noriaki
    Hara, Shuuji
    Soma, Toshihiro
    [J]. LEUKEMIA RESEARCH, 2008, 32 (03) : 512 - 514
  • [8] Treatment of newly-diagnosed acute promyelocytic leukemia with liposomal all-trans retinoic acid
    Estey, E
    Koller, C
    Cortes, J
    Reed, P
    Freireich, E
    Giles, F
    Kantarjian, H
    [J]. LEUKEMIA & LYMPHOMA, 2001, 42 (03) : 309 - 316
  • [9] Treatment of acute promyelocytic leukaemia using a combination of all-trans retinoic acid and chemotherapy
    Koh, LP
    Goh, YT
    Teoh, G
    Tan, P
    [J]. ANNALS ACADEMY OF MEDICINE SINGAPORE, 2001, 30 (04) : 401 - 408
  • [10] OUTCOME OF PATIENTS WITH NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) TREATED WITH THE COMBINATION OF ALL-TRANS RETINOIC ACID (ATRA), ARSENIC TRIOXIDE (ATO), WITH OR WITHOUT GEMTUZUMAB OZOGAMICIN (GO)
    Ravandi, F.
    Cortes, J.
    Fader, S.
    O'Brien, S.
    Pierce, S.
    Brandt, M.
    Garcia-Manero, G.
    Kantarjian, H.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 224 - 224